BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11684117)

  • 1. Medical management of dysfunctional uterine bleeding.
    Agarwal N; Kriplani A
    Int J Gynaecol Obstet; 2001 Nov; 75(2):199-201. PubMed ID: 11684117
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and management of simple ovarian cysts.
    Bayar U; Barut A; Ayoğlu F
    Int J Gynaecol Obstet; 2005 Nov; 91(2):187-8. PubMed ID: 16165135
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
    Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
    J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decidual cast after discontinuation of oral contraceptives use in a young girl.
    Sen Y; Cimbek EA; Uğraş NS
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):e127-9. PubMed ID: 23870823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
    Franchini M; Caruso C; Nigrelli S; Poggiali C
    Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of two monophase oral contraceptives with desogestrel].
    Uchikova E; Milchev N; Markova D; Batashki I; Gŭrova A
    Akush Ginekol (Sofiia); 2007; 46(2):18-21. PubMed ID: 17469446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
    Vartiainen M; de Gezelle H; Broekmeulen CJ
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
    Koyuncu FM; Kuscu NK; Var A; Onur E
    Acta Obstet Gynecol Scand; 2003 Aug; 82(8):767-8. PubMed ID: 12848650
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
    Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
    J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
    Mastorakos G; Koliopoulos C; Creatsas G
    Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethinyl estradiol plus desogestrel on premenstrual symptoms in Iranian women.
    Norouzi Javidan A; Haghollahi F; Ramezanzadeh F; Yekaninejad MS; Amiri Z; Noroozi M; Sadat Hosseini F; Azimi Nekoo E
    Acta Med Iran; 2014; 52(11):837-43. PubMed ID: 25415817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval.
    Killick SR; Fitzgerald C; Davis A
    Am J Obstet Gynecol; 1998 Jul; 179(1):S18-24. PubMed ID: 9704814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycle control with desogestrel-containing oral contraceptives--comparison of a monophasic and triphasic regimen.
    Carr BR
    Int J Fertil Menopausal Stud; 1993; 38(5):274-9. PubMed ID: 8298666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual syndrome and oral contraceptives of different character.
    Hetényi G
    Ther Hung; 1988; 36(4):170-3. PubMed ID: 3253960
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysfunctional uterine bleeding.
    Reyniak JV
    J Reprod Med; 1976 Nov; 17(5):293-5. PubMed ID: 186603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acne treatment with a new estroprogestinic biphasic combination containing desogestrel.
    Falsetti L
    Acta Eur Fertil; 1991; 22(5):283-6. PubMed ID: 1845752
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study.
    Agarwal N; Gupta M; Kriplani A; Bhatla N; Singh N
    J Obstet Gynaecol; 2016; 36(1):71-5. PubMed ID: 26204126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.